Multidisciplinary
Roxadustat may be a suitable treatment for anaemia in patients with non-dialysis dependent (NDD) chronic kidney disease (CKD), the phase III Dolomites* study showed.
Pangenotypic direct-acting antiviral (DAA) regimens, including sofosbuvir/velpatasvir (SOF/VEL), are generally effective and well tolerated in patients with hepatitis C virus (HCV) infection who fulfil guideline-recommended criteria for simplified treatment, according to data from Taiwan’s nationwide HCV registry presented at the Asian Pacific Association for the Study of the Liver (APASL) 2023 Annual Meeting.
Hong Kong
Sign In
Change Password
Points
Sign Out
